Advantages of standardized criteria for the interpretation of angiotensin-converting enzyme inhibition renography

Nuclear Medicine Communications

Volumn 30, Issue 6, 2009, Pages 449-454

  Thorsson, Ola ^a,c   Bjuvang, Agneta ^b   Granerus, Göran ^b  

^a LUND UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerotic renovascular disease; Blood pressure response to acute angiotensin converting enzyme inhibition; Captopril renography; Outcome; Renal artery stenosis; Renovascular hypertension

Indexed keywords

CAPTOPRIL; DIURETIC AGENT; ENALAPRIL; MERTIATIDE TC 99M;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PHYSICIAN; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; RENOGRAPHY; RENOVASCULAR HYPERTENSION; SENSITIVITY AND SPECIFICITY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CAPTOPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENOVASCULAR; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; RADIOISOTOPE RENOGRAPHY; REPRODUCIBILITY OF RESULTS;

EID: 67649669876     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328329fdd7     Document Type: Article

References (22)

1. Vasbinder GBC, Nelemans RJ, Kessels AGH, Kroon AA, de Leeuw PW, van Engelshoven JMA. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension. A meta-analysis. Ann Intern Med 2001; 135:401-411.
2. Taylor A, Nally J, Aurell M, Blaufox D, Dondi M, Dubovsky E, et al. Consensus report on ACE-inhibitor renography detecting renovascular hypertension. J Nucl Med 1996; 37:1876-1882.
3. Taylor A, Blaufox MD, Dubovsky E, Fine E, Fommei E, Granerus G, et al. Society of Nuclear Medicine procedure guideline for diagnosis of renovascular hypertension 3.0. Procedure guidelines, policy and practice, wivw.snm.org. http://wivw.snm.org, 2003.
4. Blaufox MD, Aurell M, Bubeck B, Fommei E, Piepsz A, Russel C, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med 1996; 37:1883-1890.
5. Cosgriff PS, Stevens D. Impact of Radionuclides in Nephrourology (RIN) guidelines. Alasbimn Journal My 2001; www.alasbimnjournal.cl. http://www.alasbimnjournal.cl
6. IMV Medical information division. 2003 Nuclear Medicine Census Marke Summary Report, IMV, Limited, Des Plaines, IL, IV (7-11).
7. Geyskes GG, Bruyn A. Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis. Am J Hypertens 1991; 4:6855-6895.
8. Blaufox D, Fine EJ, Heller S, Hurley J, Jagusr M, Li Y, er al. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. J Nucl Med 1998; 39:522-528.
9. Fine EJ. Interventions in renal scintirenography. Semin Nucl Med 1999; 29:128-145.
10. Setaro JF, Chen CC, Hoffer PB, Black HR. Captopril renography in the diagnosis of renal artery stenosis and the prediction of improvement with revascularization. Am J Hypertens 1991; 4:698-705.
11. Elliot JW, Martin WB, Murphy MB. Comparison of two non-invasive screening tests for renovascular hypertension. Arch Intern Med 1993; 153:755-763.
12. Claveau-Tremblay R, Turpin S, De Braekeleer M, Brassant A, Leblond R. False-positive captopril renography in patients taking calcium antagonists. J Nucl Med 1998; 39:1621 -1626.
13. Mittal BR, Kumar P, Arora P, Kher V, Singhal MK, Maini A, er al. Role of captopril renography in the diagnosis of renovascular hypertension. Am J Kidney Dis 1996; 28:209-213.
14. Helin KH, Tikkanen I, von Knorring JE, Lepantalo MJ, Liewendahl BK, Laasonen LS, et al. Screening for renovascular hypertension in a population with relatively low prevalence. J Hypertens 1998; 16:1523-1529.
15. Ramsay D, Belton I, Finlay D. A review of captopril test renal scintigraphy and its effect on patient management. Nucl Med Common 1997;18:631-633.
16. Caglar M, Moretti J-L, Buchet P, Weimnann P, Baillet G, Prigent A, et al. Enalapril plus fursemide MAG3 scintigraphy in hypertensive patients with arteriosclerosis and moderate renal insufficiency. Nucl Med Commun 1998;19:1135-1140.
17. Nielsen M, Granerus G, Ohlsson M, Hoist H, Thorsson O, Edenbrandt L. Interpretation of captopril renography using artificial neural networks. Clin Physiol Fund Imaging 2005; 25:293-296.
18. Krijnen P, Oei HY, Claessens RA, Roos JC. Interobserver agreement on captopril renography for assessing renal vascular disease. J Nucl Med 2002; 43:330-337.
19. Aurell M, Delin K, Granerus G. Observations on the use and limitations of renal vein renins in hypertensive patients. Con(r Nephrol 1978; 11:146-149.
20. Stavropoulos SW, Sevigny SA, Ende JF, Drane WE. Hypotensive response to captopril: a potential pitfall of scintigraphic assessment for renal artery stenosis. J Nucl Med 1999; 40:406-411.
21. Balink H, Mertens IJR, Stevens H, van Rijk PP, Beutler JJ, DeKlerk JMH. Captopril renography and the relevance of abnormal but bilateral identical curves in the diagnosis of renal artery stenosis. Nucl Med Commun 2001; 22:971-974.
22. Fanti S, Dondi M, Guidalotti PL, Lampreave JL, Romeo A, Zoboli S, er al. Bilateral symmetrical induced changes in captopril scintigraphy. J Nucl Med 1998; 39:86P.